Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.

Atik B, Johnston SC, Dean D.

PLoS One. 2010 Jun 9;5(6):e11026. doi: 10.1371/journal.pone.0011026.

2.

Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.

Mannheim D, Herrmann J, Versari D, Gössl M, Meyer FB, McConnell JP, Lerman LO, Lerman A.

Stroke. 2008 May;39(5):1448-55. doi: 10.1161/STROKEAHA.107.503193. Epub 2008 Mar 20.

3.

Chlamydia pneumoniae burden in carotid arteries is associated with upregulation of plaque interleukin-6 and elevated C-reactive protein in serum.

Johnston SC, Zhang H, Messina LM, Lawton MT, Dean D.

Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2648-53. Epub 2005 Oct 6.

PMID:
16210572
4.

Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome.

Herrmann J, Mannheim D, Wohlert C, Versari D, Meyer FB, McConnell JP, Gössl M, Lerman LO, Lerman A.

Eur Heart J. 2009 Dec;30(23):2930-8. doi: 10.1093/eurheartj/ehp309. Epub 2009 Aug 17.

5.

The association of carotid plaque inflammation and Chlamydia pneumoniae infection with cerebrovascular symptomatology.

Kaperonis EA, Liapis CD, Kakisis JD, Perrea D, Kostakis AG, Karayannakos PE.

J Vasc Surg. 2006 Dec;44(6):1198-204.

6.

Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis.

Vickers KC, Maguire CT, Wolfert R, Burns AR, Reardon M, Geis R, Holvoet P, Morrisett JD.

J Lipid Res. 2009 Sep;50(9):1735-43. doi: 10.1194/jlr.M800342-JLR200. Epub 2009 Apr 9.

7.

Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.

Gong HP, Du YM, Zhong LN, Dong ZQ, Wang X, Mao YJ, Lu QH.

Lipids Health Dis. 2011 Jan 19;10:13. doi: 10.1186/1476-511X-10-13.

8.

Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.

Elkind MS, Tai W, Coates K, Paik MC, Sacco RL.

Cerebrovasc Dis. 2009;27(1):42-50. doi: 10.1159/000172633. Epub 2008 Nov 15.

9.

Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study.

Brilakis ES, Khera A, Saeed B, Banerjee S, McGuire DK, Murphy SA, de Lemos JA.

Clin Chem. 2008 Dec;54(12):1975-81. doi: 10.1373/clinchem.2008.107359. Epub 2008 Oct 2.

10.

Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation.

Gonçalves I, Edsfeldt A, Ko NY, Grufman H, Berg K, Björkbacka H, Nitulescu M, Persson A, Nilsson M, Prehn C, Adamski J, Nilsson J.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1505-12. doi: 10.1161/ATVBAHA.112.249854. Epub 2012 Apr 12.

PMID:
22499993
11.

Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A2 activity in atherosclerotic plaque.

Otsuka F, Zhao X, Trout HH, Qiao Y, Wasserman BA, Nakano M, Macphee CH, Brandt M, Krug-Gourley S, Guo L, Ladich ER, Cheng Q, Davis HR, Finn AV, Virmani R, Kolodgie FD.

Atherosclerosis. 2017 Dec;267:78-89. doi: 10.1016/j.atherosclerosis.2017.10.014. Epub 2017 Oct 14.

PMID:
29101839
12.

[Association between carotid atherosclerosis, inflammatory markers and Chlamydia pneumoniae infection].

Kaźmierski R, Podsiadły E, Tylewska-Wierzbanowska S, Kozubski W.

Neurol Neurochir Pol. 2005 Jul-Aug;39(4):277-86. Polish.

PMID:
16096932
13.

C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis.

Johnston SC, Messina LM, Browner WS, Lawton MT, Morris C, Dean D.

Stroke. 2001 Dec 1;32(12):2748-52.

PMID:
11739967
14.

[Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors].

Jia ZR, Zhao D, Qi Y, Wang W, Wang M, Sun JY, Qin LP, Liu J.

Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Nov;41(11):962-7. Chinese.

PMID:
24370228
15.

Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients.

Delgado P, Chacón P, Penalba A, Pelegri D, García-Berrocoso T, Giralt D, Santamarina E, Ribó M, Maisterra O, Alvarez-Sabín J, Rosell A, Montaner J.

Cerebrovasc Dis. 2012;33(2):150-8. doi: 10.1159/000334193. Epub 2011 Dec 14.

PMID:
22178747
16.

Amelioration of atherosclerosis in apolipoprotein E-deficient mice by inhibition of lipoprotein-associated phospholipase A2.

Zhang H, Zhang JY, Sun TW, Shen DL, He F, Dang YH, Li L.

Clin Invest Med. 2013 Feb 1;36(1):E32-41.

PMID:
23374598
17.

Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.

Epps KC, Wilensky RL.

J Intern Med. 2011 Jan;269(1):94-106. doi: 10.1111/j.1365-2796.2010.02297.x. Epub 2010 Nov 5. Review.

18.

Regression of atherosclerosis in apolipoprotein E-deficient mice by lentivirus-mediated gene silencing of lipoprotein-associated phospholipase A2.

Zhang H, Zhang J, Shen D, Zhang L, He F, Dang Y, Li L.

Biochem Biophys Res Commun. 2012 Oct 26;427(3):557-62. doi: 10.1016/j.bbrc.2012.09.096. Epub 2012 Sep 26.

PMID:
23022183
19.

Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study.

Nambi V, Hoogeveen RC, Chambless L, Hu Y, Bang H, Coresh J, Ni H, Boerwinkle E, Mosley T, Sharrett R, Folsom AR, Ballantyne CM.

Stroke. 2009 Feb;40(2):376-81. doi: 10.1161/STROKEAHA.107.513259. Epub 2008 Dec 18.

20.

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.

Mohler ER 3rd, Ballantyne CM, Davidson MH, Hanefeld M, Ruilope LM, Johnson JL, Zalewski A; Darapladib Investigators.

J Am Coll Cardiol. 2008 Apr 29;51(17):1632-41. doi: 10.1016/j.jacc.2007.11.079.

Supplemental Content

Support Center